DORCHESTER WEALTH MANAGEMENT Co Has $178,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

DORCHESTER WEALTH MANAGEMENT Co cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 66.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,028 shares of the pharmacy operator’s stock after selling 38,125 shares during the period. DORCHESTER WEALTH MANAGEMENT Co’s holdings in Walgreens Boots Alliance were worth $178,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of WBA. First Financial Corp IN boosted its position in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter valued at approximately $28,000. TD Private Client Wealth LLC raised its stake in Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the period. Finally, Sentry Investment Management LLC bought a new stake in Walgreens Boots Alliance in the third quarter valued at approximately $30,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA opened at $10.16 on Friday. The business’s 50 day moving average is $10.37 and its 200-day moving average is $9.70. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a market cap of $8.78 billion, a P/E ratio of -0.99, a price-to-earnings-growth ratio of 1.31 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the company earned $0.66 EPS. The company’s revenue was up 7.6% on a year-over-year basis. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on WBA. Truist Financial dropped their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Royal Bank of Canada upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $12.63.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.